Vimarsana
Biggest News Aggregation in the World

Aardex Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aardex Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aardex Group Today - Breaking & Trending Today

Cambridge Cognition and Aardex collaborate to boost decentralised clinical trials - Vimarsana News

Cambridge Cognition and Aardex collaborate to boost decentralised clinical trials

Partnership involves the study of real-time patient data and identification of adherence issues - News - PharmaTimes

Adherence Monitoring Caps Market 2021 Production, Revenue, Industry Market Share, Regional Growth Analysis, Upcoming Trends, Key Manufacturers, Development Analysis Research Report by 2028 - Vimarsana News

Adherence Monitoring Caps Market 2021 Production, Revenue, Industry Market Share, Regional Growth Analysis, Upcoming Trends, Key Manufacturers, Development Analysis Research Report by 2028

Adherence Monitoring Caps Market 2021 Production, Revenue, Industry Market Share, Regional Growth Analysis, Upcoming Trends, Key Manufacturers, Development Analysis Research Report by 2028 iCrowd Newswire Global Adherence Monitoring Caps Industry 2021 Market Research Report is an in-depth study providing a complete analysis of the Adherence Monitoring Caps Market for the period 2021–2028. It provides a complete overview of market size, share, growth, trends, industry chain structure, top manufacturers, market dynamics and competitive scenario. Download Sample Copy of This Report @ investm...

Schreiner develops medication adherence technology - Vimarsana News

Schreiner develops medication adherence technology

Schreiner MediPharm has partnered with Aardex Group, an expert in digital medication adherence, to develop electronic technology for medication adherence monitoring during clinical trials. According to Schreiner, up to 50 percent of patients involved in clinical trials do not adhere to the prescribed dosage regimen, resulting in distorted outcomes such as insufficient drug efficacy or underestimated frequency of side effects. Ultimately, these adverse events can delay time to market.  Schreiner's therapy monitoring technology consists of Smart Blister Packs for tablets and Smart Kit Boxes f...